We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$113B
1-Year Est. Return
38.87%
This Fund
S&P 500
This Quarter
Est. Return
+0.94%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+500.61%
AUM
$67.9B
AUM Growth
-$1.92B
(-2.7%)
Cap. Flow
-$1.61B
Cap. Flow
% of AUM
-2.37%
Top 10 Holdings %
Top 10 Hldgs %
16.65%
Holding
792
New
60
Increased
302
Reduced
281
Closed
78
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$761M |
| 2 |
PPG Industries
PPG
|
+$342M |
| 3 |
Pultegroup
PHM
|
+$278M |
| 4 |
Apple
AAPL
|
+$233M |
| 5 |
UnitedHealth
UNH
|
+$211M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$701M |
| 2 |
Medtronic
MDT
|
+$355M |
| 3 |
Lockheed Martin
LMT
|
+$309M |
| 4 |
TW
TOWERS WATSON & CO COM STK CL A (DE)
TW
|
+$286M |
| 5 |
Western Digital
WDC
|
+$252M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 26.4% |
| 2 | Technology | 13.5% |
| 3 | Healthcare | 12.95% |
| 4 | Industrials | 11.69% |
| 5 | Energy | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Berkshire Hathaway Class B
BRK.B
$1.08T
| $1.57B | 2.31% |
11,071,407
+424,040
| +4% | +$56.2M |
|
2
JPMorgan Chase
JPM
$942B
| $1.53B | 2.25% |
25,767,714
-681,544
| -3% | -$39.8M |
|
3
Johnson & Johnson
JNJ
$640B
| $1.44B | 2.12% |
13,272,381
+1,985,756
| +18% | +$206M |
|
4
Capital One
COF
$133B
| $1.13B | 1.67% |
16,357,975
-89,680
| -0.5% | -$5.93M |
|
5
Wells Fargo
WFC
$257B
| $1.09B | 1.61% |
22,591,838
-2,754,645
| -11% | -$135M |
|
6
Microsoft
MSFT
$3.75T
| $1.09B | 1.6% |
19,655,987
-3,438,710
| -15% | -$180M |
|
7
Citigroup
C
$223B
| $944M | 1.39% |
22,613,078
-740,024
| -3% | -$30.9M |
|
8
Phillips 66
PSX
$95.7B
| $860M | 1.27% |
9,937,291
+386,053
| +4% | +$31.4M |
|
9
Occidental Petroleum
OXY
$59.1B
| $844M | 1.24% |
12,327,695
-2,017,178
| -14% | -$135M |
|
10
Merck
MRK
$369B
| $814M | 1.2% |
16,116,836
+783,358
| +5% | +$38.4M |
|
|
11
Bank of America
BAC
$428B
| $795M | 1.17% |
58,780,917
+56,362,516
| +2,331% | +$761M |
|
12
Verizon
VZ
$205B
| $791M | 1.17% |
14,633,462
+971,279
| +7% | +$48.6M |
|
|
DFS
13
DELISTED
Discover Financial Services
DFS
| $761M | 1.12% |
14,943,210
+184,534
| +1% | +$8.89M |
|
14
Oracle
ORCL
$438B
| $747M | 1.1% |
18,253,131
+2,742,707
| +18% | +$102M |
|
15
Chubb
CB
$131B
| $728M | 1.07% |
6,108,564
-755,103
| -11% | -$86.8M |
|
16
Cisco
CSCO
$442B
| $716M | 1.05% |
25,138,586
-6,046,722
| -19% | -$156M |
|
17
Delta Air Lines
DAL
$53.4B
| $676M | 1% |
13,881,734
+876,451
| +7% | +$40.9M |
|
18
Flex
FLEX
$42.6B
| $673M | 0.99% |
74,092,887
+11,087,236
| +18% | +$89.1M |
|
19
Hewlett Packard
HPE
$72B
| $655M | 0.96% |
63,528,987
+5,176,699
| +9% | +$43.4M |
|
20
EOG Resources
EOG
$75.8B
| $640M | 0.94% |
8,823,577
-983,532
| -10% | -$68M |
|
21
Allstate
ALL
$65.1B
| $625M | 0.92% |
9,280,193
+1,455,276
| +19% | +$91.4M |
|
|
FITB
22
Fifth Third Bancorp
FITB
$49.7B
| $625M | 0.92% |
37,440,767
+1,056,205
| +3% | +$17.4M |
|
|
ATVI
23
DELISTED
Activision Blizzard
ATVI
| $615M | 0.91% |
18,165,266
-6,434,807
| -26% | -$211M |
|
24
Aon
AON
$74.2B
| $607M | 0.89% |
5,809,555
+2,016
| +0% | +$189K |
|
25
Gilead Sciences
GILD
$185B
| $605M | 0.89% |
6,589,500
-253,682
| -4% | -$22.9M |
|
Similar funds
Boston Partners's Q1 2016 Portfolio in Review
As of Q1 2016, Boston Partners held 792 positions worth $67.9B, down 2.7% from $69.8B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Boston Partners's Q1 2016 filing shows 60 new, 302 increased, 281 reduced and 78 closed positions. Its largest new stake was Pultegroup: 16,274,531 shares worth $304M. The largest sale was Pfizer, an estimated $701M.
By sector, the portfolio is most concentrated in Financials at 26% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.
- Boston Partners's largest Q1 2016 buy was Pultegroup: 16,274,531 shares worth $304M.
- Boston Partners added most to Bank of America in Q1 2016, an estimated $761M increase.
- Boston Partners's biggest Q1 2016 reduction was Pfizer, cutting an estimated $701M.
- Boston Partners fully exited TOWERS WATSON & CO COM STK CL A (DE) in Q1 2016, selling an estimated $286M.
- Boston Partners's ten largest holdings make up 17% of its $67.9B portfolio in Q1 2016.
- Boston Partners opened 60 new positions and closed 78 in Q1 2016.
- Boston Partners's portfolio value fell 2.7% quarter-over-quarter to $67.9B.
Based on Boston Partners's 13F filing for Q1 2016, filed 12 May 2016.